In order to actively promote the implementation of the “Healthy China” strategy, promote the development of China’s peptide health industry, and give full play to the major role of the peptide industry in health.
On June 26, 2022, the “China Health Care Association Peptide and Health Industry Branch Inaugural Meeting and Co-creation of Vitality Peptide Industry Development Seminar” hosted by China Health Care Association and undertaken by Taiai Peptide Group was successfully held in Beijing. Huang Jiansheng, Executive Vice Chairman of China Health Care Association, Xu Huafeng, Vice Chairman and Secretary General of China Health Care Association, Li Ping, Vice Chairman of China Health Care Association, Wu Xia, Chairman of Taiai Peptide Group, Ren Yan, double doctorate degree in traditional Chinese medicine and clinical nutrition Ding Gangqiang, Director of the Nutrition and Health Institute of the Chinese Center for Disease Control and Prevention, Qiao Wei, President of Sales and Marketing Operations of Taiai Peptide Group, Chen Ye, Chief Executive Officer of Taiai Peptide Group, Wang Fabing, Chairman of Shandong Peptide Dingwu Technology Co., Ltd., Chongqing Jiaer Biotechnology Co., Ltd. Li Changjun, general manager of the Institute of Technology, Zhao Qingguo, general manager of Henan Yikang Youpin Health Management Co., Ltd., as well as nearly 100 people including representatives of online participating companies and business leaders attended the meeting. The meeting was hosted by Li Ping, vice chairman of China Health Care Association. Ms. hosted.
Li Ping, vice chairman of China Health Care Association, presided over the meeting.
At the inauguration ceremony, Vice Chairman Li Ping emphasized in the background of the establishment of the Peptide and Health Industry Branch of China Health Care Association: China Health Care Association is an industry association established in 2003 by the Ministry of Health and the Ministry of Civil Affairs and reported to the State Council for approval. serve enterprises, serve consumers”. She also pointed out that the establishment of the Peptide and Health Industry Branch of the China Health Care Association complies with and meets people’s needs for big health.
Huang Jiansheng, executive vice chairman of China Health Care Association, read the announcement of the establishment of the branch.
In the election of the branch leader, Vice Chairman Li Ping read out the candidate list for the leader of the Peptide and Health Industry Branch on the spot and made the final election resolution of the conference: it was unanimously agreed that Wu Xia, Chairman of Taiai Peptide, would serve as the branch president, and Sinopharm Peptide Valley Co., Ltd. Shi Feng, president of the company, served as the secretary general of the branch, Liu Xia, chairman of Shandong Hualong Group, served as the vice president of the branch, and Zhao Xuhui of Taiai peptide served as the executive deputy secretary general.
Huang Jiansheng, the executive vice chairman, issued the branch certificate, and awarded the board to the Tai Ai Peptide director unit and the member unit.Huang Jiansheng, the executive vice chairman, awarded the board of Tai Ai Peptide Council.
Wu Xia, elected president of the Peptide and Health Industry Branch of China Health Care Association, delivered an inaugural speech.
Wu Xia, Chairman of Taiai Peptide, delivered a speech on the inauguration of the President of Peptide and Health Industry Branch.
In his inaugural speech, President Wu said: As the president of the branch, I have an obligation to the development of the branch. In the future, under the leadership and support of the general meeting, the branch will thoroughly implement the Healthy China strategy to “assist the government, help enterprises, With the purpose of “serving consumers”, it will carry out activities in the fields related to peptides and the big health industry, and build the “Peptide and Health Industry Branch” into a professional, standardized and standardized industry authority branch, and provide R&D support for the health industry and member units. technical support, sales support and other all-round services and assistance, play the role of bridge and link between members and the government. Promote the development of China’s health industry and help a healthy China!Professor Ding Gangqiang, Director of the Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention, shared online.
Professor Ding Gangqiang first expounded the importance of peptides to human health from different perspectives. He said: In China, the pressure of an aging society is relatively high. The elderly over the age of 60 account for 18.3% of the total population, and the elderly over the age of 65 account for 13.5%. With the increase of age, the physiological functions of the elderly degenerate, amino acids, peptides, and proteins can make their immune function stronger; the current country pays special attention to people’s health, especially in the current epidemic, so that each of us can have a healthy The establishment of the Peptide and Health Industry Branch under the China Health Care Association is of great significance. It is of great significance to unite our good enterprises to discuss the biological mechanism of the development of related peptides and the promotion of macro policies.
Online sharing by Dr. Yandong Ren, a double doctorate in traditional Chinese medicine and clinical nutrition.
Dr. Ren Yandong said in his speech that the establishment of the Peptide and Health Industry Branch is a weather vane for the industry. President Wu Xia has always been committed to promoting the development of the peptide industry and driving the industry to a higher level. In today’s clinical nutrition research, peptides are used as the basic raw materials of proteins, and multi-functional peptides have become the focus of global nutrition. The products researched by Taiai Peptide have both top-level technical structure design and technological breakthroughs, which have driven the development of the health industry in the field of nutrition. Last year, I also conducted in-depth research on peptide supplements for osteoarthritis with President Wu Xia. Through clinical experiments, we have seen gratifying results of peptide nutritional supplements in the prevention and treatment of chronic diseases. From the perspective of chronic diseases, the development of peptide nutritional supplements and the industry can indeed drive technologies and services for the prevention and treatment of chronic diseases in China.Xu Huafeng, vice chairman and secretary general, mentioned in his speech: President Wu Xia and the companies in the industry chain have communicated with the association and the official establishment of the branch today. a process. It is hoped that under the purpose of the health care association, the peptide and health industry branch can better promote the improvement of health-related policies, promote the standardized development of the health industry, promote the implementation of the Healthy China strategy, and promote the health literacy level of the people. improvement.
The establishment of the Peptide and Health Industry Branch marks the establishment of a new social integration mechanism and communication platform in the field of peptides and health in China.)”, to promote the cause of national health, and to build an industry exchange platform. It has important practical significance and far-reaching historical significance for accelerating the standardization and standardization process of people’s country’s peptide industry, promoting the healthy development of the peptide industry, and accelerating the transformation of the scientific research results of the peptide industry into the big health industry.
Taiai Peptide Group has been focusing on the field of small molecule peptides for 25 years, and has developed into a group company integrating R&D, production, sales and service, and has a number of core technology patents. The group has always adhered to the research and development spirit of “endless life, endless scientific research”, and always takes “letting the common people drink peptides and have a good body” as its corporate mission. It has more than 300 scientific research achievements, more than 50 independent products, 10 The 10,000-level GMP workshop standard has a production capacity of more than 5,000 tons. After the Taiai peptide production base in Heze, Shandong is put into operation in 2022, it will reach a daily production capacity of 150,000 boxes. After continuous innovation and development, the market covers diversified business sectors such as special meals, cosmetics, and international trade. Provide overall solutions such as original powder, ODM, OEM, brand agency and so on for the world.
Taiai Peptide Group will give full play to its position and advantages in China’s peptide industry, integrate resources, focus on industrial scientific research and capital, achievements and markets, provide a full range of services and assistance for the health industry and member units, and help the development of the peptide and health industry branch, to make positive contributions to the positive development of China’s bioactive peptide industry, and to help the health of the people!
Media Contact
Company Name: Shandong Taiai Peptide Biotechnology Co., Ltd.
Email: Send Email
Phone: 0086-19933321205
Address:The right side of Guihua 1st Road, Heze Modern Medicine Port, Changjiang East Road, Development Zone
City: Heze
State: Shandong
Country: China
Website: https://www.taiaitaibiology.com/